BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18202147)

  • 21. Specificity of NHERF1 regulation of GPCR signaling and function in human airway smooth muscle.
    Pera T; Tompkins E; Katz M; Wang B; Deshpande DA; Weinman EJ; Penn RB
    FASEB J; 2019 Aug; 33(8):9008-9016. PubMed ID: 31042404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
    Yang Y; Wang B
    Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small molecule inhibition of the Na(+)/H(+) exchange regulatory factor 1 and parathyroid hormone 1 receptor interaction.
    Fitzpatrick JM; Pellegrini M; Cushing PR; Mierke DF
    Biochemistry; 2014 Sep; 53(37):5916-22. PubMed ID: 25171053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NHERF1 regulation of PTH-dependent bimodal Pi transport in osteoblasts.
    Wang B; Yang Y; Liu L; Blair HC; Friedman PA
    Bone; 2013 Jan; 52(1):268-77. PubMed ID: 23046970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RGS14 regulates PTH- and FGF23-sensitive NPT2A-mediated renal phosphate uptake via binding to the NHERF1 scaffolding protein.
    Friedman PA; Sneddon WB; Mamonova T; Montanez-Miranda C; Ramineni S; Harbin NH; Squires KE; Gefter JV; Magyar CE; Emlet DR; Hepler JR
    J Biol Chem; 2022 May; 298(5):101836. PubMed ID: 35307350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EBP50 inhibits the anti-mitogenic action of the parathyroid hormone type 1 receptor in vascular smooth muscle cells.
    Song GJ; Barrick S; Leslie KL; Sicari B; Fiaschi-Taesch NM; Bisello A
    J Mol Cell Cardiol; 2010 Dec; 49(6):1012-21. PubMed ID: 20843475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ezrin-anchored protein kinase A coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport.
    Wang B; Means CK; Yang Y; Mamonova T; Bisello A; Altschuler DL; Scott JD; Friedman PA
    J Biol Chem; 2012 Jul; 287(29):24148-63. PubMed ID: 22628548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation.
    Rey A; Manen D; Rizzoli R; Caverzasio J; Ferrari SL
    J Biol Chem; 2006 Dec; 281(50):38181-8. PubMed ID: 17038311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alteration in the sensitivity to crizotinib by Na
    Yang F; Hu M; Chang S; Huang J; Si Y; Wang J; Cheng S; Jiang WG
    BMC Cancer; 2020 Mar; 20(1):202. PubMed ID: 32164629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NHERF1 PDZ1 domain and IRBIT interact and mediate the activation of Na+/H+ exchanger 3 by ANG II.
    He P; Zhao L; No YR; Karvar S; Yun CC
    Am J Physiol Renal Physiol; 2016 Aug; 311(2):F343-51. PubMed ID: 27279487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of NHERF1/EBP50 in cancer.
    Georgescu MM; Morales FC; Molina JR; Hayashi Y
    Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments.
    Sneddon WB; Magyar CE; Willick GE; Syme CA; Galbiati F; Bisello A; Friedman PA
    Endocrinology; 2004 Jun; 145(6):2815-23. PubMed ID: 15016722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization.
    Sneddon WB; Friedman PA
    Endocrinology; 2007 Aug; 148(8):4073-9. PubMed ID: 17525124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of interactions of Na+/H+ exchanger regulatory factor-1 with the parathyroid hormone receptor and phospholipase C.
    Sun C; Mierke DF
    J Pept Res; 2005 Mar; 65(3):411-7. PubMed ID: 15787971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VIP regulates CFTR membrane expression and function in Calu-3 cells by increasing its interaction with NHERF1 and P-ERM in a VPAC1- and PKCε-dependent manner.
    Alshafie W; Chappe FG; Li M; Anini Y; Chappe VM
    Am J Physiol Cell Physiol; 2014 Jul; 307(1):C107-19. PubMed ID: 24788249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
    Gu Y; Yu H; Hao C; Martin TA; Hargest R; He J; Cheng S; Jiang WG
    Oncotarget; 2017 Jan; 8(5):7753-7765. PubMed ID: 27999191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Na(+)/H(+ ) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling.
    Mahon MJ; Donowitz M; Yun CC; Segre GV
    Nature; 2002 Jun; 417(6891):858-61. PubMed ID: 12075354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Na+-H+ exchanger regulatory factor 1 (NHERF1) PDZ scaffold binds an internal binding site in the scavenger receptor megalin.
    Slattery C; Jenkin KA; Lee A; Simcocks AC; McAinch AJ; Poronnik P; Hryciw DH
    Cell Physiol Biochem; 2011; 27(2):171-8. PubMed ID: 21325834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From parathyroid hormone to cytosolic Ca2+ signals.
    Taylor CW; Tovey SC
    Biochem Soc Trans; 2012 Feb; 40(1):147-52. PubMed ID: 22260681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
    Sun J; Li P; Yang J
    Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.